Skip to content

9 Minutes for Colonoscopy Withdrawal

Impact of 9-minute Withdrawal Time on Adenoma Detection Rate:a Multicenter, Prospective, Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03399045
Enrollment
1027
Registered
2018-01-16
Start date
2018-01-20
Completion date
2019-07-06
Last updated
2020-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Polyps, Colorectal Adenomas

Brief summary

A withdrawal time of at least 6 minutes has been considered to be necessary to guarantee the adenoma detection rate and the critical quality criterion of colonoscopy. However, several large observational investigations demonstrated that 9 minutes will be in favor of higher adenoma detection rate and lower risk of interval colorectal cancer, when compared with 6-minute withdrawal. Meanwhile, a few studies also indicated that no significant benefit were observed in longer withdrawal time. Up to now, no randomized controlled trials have been conducted to give a definitive conclusion. Therefore, we performed a multicenter, prospective, randomized Controlled trial to compare adenoma detection rate of 6-minute and 9-minute withdrawal in colonoscopy.

Interventions

PROCEDURE9-minute withdrawal

Patients in 9-minute withdrawal group will be carefully observed for 9 minutes during the colonoscopy withdraw

PROCEDURE6-minute withdrawal

Patients in 6-minute withdrawal group will be carefully observed for 6 minutes during the colonoscopy withdraw

Sponsors

No.85 Hospital, Changning, Shanghai, China
CollaboratorOTHER
The Second Clinical Medical College of Jinan University
CollaboratorOTHER
Qinghai People's Hospital
CollaboratorOTHER
Shaanxi Provincial People's Hospital
CollaboratorOTHER
Shanghai 8th People's Hospital
CollaboratorOTHER
Yantaishan Hospital of Yantai City
CollaboratorUNKNOWN
First Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
Changzhi People's Hospital
CollaboratorOTHER
Ningbo Medical Center Li Huili Eastern Hospital
CollaboratorUNKNOWN
The Third People's Hospital of Datong
CollaboratorUNKNOWN
The First Affiliated Hospital of the Medical College, Shihezi University
CollaboratorUNKNOWN
The First Affiliated Hospital of Dalian Medical University
CollaboratorOTHER
Seventh Medical Center of PLA Army General Hospital
CollaboratorOTHER
Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients whose age is between 40-85. * Patients who have indications for screening, surveillance and diagnostic colonoscopy. * Patients who have signed inform consent form

Exclusion criteria

* Patients who have undergone colonic resection * Patients with intracranial and/or central nervous system disease, including cerebral infarction and cerebral hemorrhage. * Patients with severe chronic cardiopulmonary and renal disease. * Patients who are unwilling or unable to consent. * Patients who are not suitable for colonoscopy * Patients who received urgent or therapeutic colonoscopy * Patients with pregnancy, inflammatory bowel disease, polyposis of colon, colorectal cancer, or intestinal obstruction * Patients who are taking aspirin, clopidogrel or other anticoagulants * Patients with Aronchick score \> 3

Design outcomes

Primary

MeasureTime frameDescription
adenoma detection rate(ADR)30minsADR was calculated adenoma detection rate is the number of patients with at least one adenoma, divided by the total number of patients.

Secondary

MeasureTime frameDescription
adenomas per colonoscopy(APC)30minsAPC was calculated as the number of adenomas detected during colonoscopy withdraw divided by the number of colonoscopies.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026